Protalix BioTherapeutics
PLX
#8626
Rank
ยฃ0.10 B
Marketcap
ยฃ1.40
Share price
1.15%
Change (1 day)
-1.24%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ23.16 Million

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are ยฃ23.16 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ39.92 M-27.29%
2022-12-31ยฃ54.9 M-7.01%
2021-12-31ยฃ59.04 M-15.26%
2020-12-31ยฃ69.67 M-21.04%
2019-12-31ยฃ88.24 M-1.75%
2018-12-31ยฃ89.81 M19.4%
2017-12-31ยฃ75.22 M0.67%
2016-12-31ยฃ74.72 M28.2%
2015-12-31ยฃ58.28 M-32.25%
2014-12-31ยฃ86.04 M1.17%
2013-12-31ยฃ85.04 M67.46%
2012-12-31ยฃ50.78 M1.35%
2011-12-31ยฃ50.1 M1.71%
2010-12-31ยฃ49.26 M-3.7%
2009-12-31ยฃ51.16 M1059.98%
2008-12-31ยฃ4.41 M96.81%
2007-12-31ยฃ2.24 M62.34%
2006-12-31ยฃ1.38 M110.67%
2005-12-31ยฃ0.65 M1671.84%
2004-12-31ยฃ0.03 M-16.07%
2003-12-31ยฃ0.04 M-10.65%
2002-12-31ยฃ0.04 M-7.47%
2001-12-31ยฃ0.05 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.48 B 1,986.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.64 B 2,701.96%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ100.94 B 435,655.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ28.13 B 121,351.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel